Bipolar 1 Disorder Clinical Trial
Official title:
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Safety and Efficacy Study of Oral ELND005 as an Adjunctive Maintenance Treatment in Patients With Bipolar I Disorder
The primary purpose of this study is to determine whether ELND005 is effective in the maintenance treatment of bipolar 1 disorder when added to other therapies.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400785 -
Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning
|
N/A | |
| Withdrawn |
NCT01981811 -
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
|
Phase 2 | |
| Recruiting |
NCT04580134 -
CLOZAPINE Response in Biotype-1
|
Phase 4 | |
| Terminated |
NCT03643159 -
A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
|
Phase 4 | |
| Completed |
NCT02050854 -
Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
|
N/A | |
| Completed |
NCT01396291 -
Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)
|
Phase 3 | |
| Completed |
NCT03386851 -
Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder
|
||
| Completed |
NCT00764478 -
Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)
|
Phase 3 |